External Assessment

Santen seeks to identify social issues and expectations for us through communication with stakeholders, in order to reflect such findings in our sustainability promotion activities.

Selected for ESG Indexes

Various ESG indexes are used to benchmark responsible investment. ESG indexes evaluate companies from non-financial, environmental, social and governance (ESG) perspective, with the aim of promoting responsible investment from a long-term viewpoint. Santen Group's sustainability promotion efforts have been evaluated from the perspective of ESG and selected in ESG indexes inside and outside of Japan.

Indexes
FTSE4Good Index Series

Index Series developed by FTSE Russell in the United Kingdom. The index series select companies based on evaluations of their initiatives in the areas of Environmental, Social and Governance(ESG) activities.

FTSE4Good Index SeriesFTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirm that Santen Pharmaceutical has been independently assessed according to the FTSE4Good criteria, and has satisfied the requirements to become a constituent of the FTSE4Good Index Series. Created by the global index provider FTSE Russell, the FTSE4Good Index Series is designed to is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE4Good indices are used by a wide variety of market participants to create and assess responsible investment funds and other products.
Sompo Sustainability Index

An index composed of corporations that achieved above-standard ESG scores in corporate surveys conducted by Sompo Risk Management & Health Care Inc. (in terms of E: environmental assessments) and by Integrex Inc. (in terms of S and G: social and corporate governance assessments).

Sompo Sustainability Index

Santen includes in all four ESG investment indexes selected by GPIF

Japan's Government Pension Investment Fund (GPIF), the world's largest institutional investor, has selected four ESG indexes for Japanese equities and has started investment based on those indexes. Santen is a constituent stock in all four indexes.

Indexes
FTSE Blossom Japan Index

A broad index developed by FTSE Russell in the United Kingdom. The index is incorporating overall ESG considerations.

FTSE Blossom Japan IndexFTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirm that Santen Pharmaceutical has been independently assessed according to the index criteria, and has satisfied the requirements to become a constituent of the FTSE Blossom Index Series. Created by the global index provider FTSE Russell, the FTSE Blossom Index Series is designed to is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE Blossom Index are used by a wide variety of market participants to create and assess responsible investment funds and other products.
MSCI Japan ESG Select Leaders Index

An index developed by MSCI in the United States. The index selects companies based on high ESG ratings in their respective industries ESG

MSCI Japan ESG Select Leaders IndexThe inclusion of Santen Pharmaceutical in any MSCI index, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement or promotion of Santen Pharmaceutical by MSCI or any of its affiliates.The MSCI indexes are the exclusive property of MSCI. MSCI and the MSCI index names and logos are trademarks or service of MSCI or its affiliates.
MSCI Japan Empowering Women Index (WIN)

An index developed by MSCI in the United States. The index selects companies in various sectors that excel in gender diversity from among the top Japanese stocks by market capitalization.

MSCI Japan Empowering Women Index (WIN)The inclusion of Santen Pharmaceutical in any MSCI index, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement or promotion of Santen Pharmaceutical by MSCI or any of its affiliates.The MSCI indexes are the exclusive property of MSCI. MSCI and the MSCI index names and logos are trademarks or service of MSCI or its affiliates.
S&P/JPX Carbon Efficient Index

An Index developed by S&P Dow Jones Indices in the United States. The index evaluates corporate performance in terms of disclosure of information carbon efficiency.

S&P/JPX Carbon Efficient Index

Recognition and Commendations by Third Parties

Below are the main recognition and commendations Santen has received.

March 2021

Santen has been certificated as One of Outstanding Enterprises in 2021 Certified Health and Productivity Management Outstanding Organization (Large Enterprise Category)

2021 Certified Health and Productivity Management Outstanding Organization
January 2021

Santen Pharmaceutical Spain, S.L. has been certificated as Great Place To Work® SPAIN

Great Place To Work SPAIN
June 2020

Santen Italy S.r.l. has been certificated as Great Place To Work® ITALIA for the second consecutive year

Great Place To Work ITALIA
January 2019

Claire, a special subsidiary company got certified as a company which persons with disabilities work actively by Japan Association of Employers of Persons with Severe Disabilities, which is a trustee organization entrusted to the Ministry of Health, Labor and Welfare.

February 2018

Santen was selected for the winner of the Corporate Governance of the year 2017 by the Japan Association of Corporate Directors.

Recognized for:
As a company which have achieved and maintained long term profitability by implementing good corporate governance.